ema glp-1 vision loss recommendation ophthalmology november 2025 Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic optic neuropathy or # EMA Warns of Vision Risk

Scientists had long suspected it could be there, given the hormones role elsewhere in the body, but no one had shown it

Explore savings alternatives : You can use manufacturer coupons, alternative medications, or compounded options if your coverage is denied If youre exploring weight-loss medication options, youve likely come across Wegovy

Comprehensive testing protocols for consistent product performance across all batches

This helps protect neurons from damage and supports cognitive function

The level of AOPPs was significantly lower in ChT + amlodipine (29%), ChT + aminoguanidine (26%), and ChT + NAC (68%) than in ChT alone